Endpoint

Rivus Pharmaceuticals’ Phase 2a HuMAIN Trial Meets Primary Endpoint of Weight Loss and Secondary Endpoints in Patients with Obesity-Related Heart Failure

Rivus Pharmaceuticals’ Phase 2a HuMAIN Trial Meets Primary Endpoint of Weight Loss and Secondary Endpoints in Patients with Obesity-Related Heart Failure

admin August 16, 2024 0

– Data from the HuMAIN study in patients with obesity-related heart failure with preserved ejection fraction (HFpEF) will be presented...

Read More

Endocrinology Researcher Receives Top American Science Award

Endocrinology Researcher Receives Top American Science Award

admin January 14, 2025 0

Strengthening Families’ Healthy Eating Habits for 40 Years

Strengthening Families’ Healthy Eating Habits for 40 Years

admin January 14, 2025 0

Mass General Brigham introduces new masking policy as respiratory illnesses rise

Mass General Brigham introduces new masking policy as respiratory illnesses rise

admin January 14, 2025 0

RNA’s influence on sugar metabolism could transform gut health strategies

RNA’s influence on sugar metabolism could transform gut health strategies

admin January 14, 2025 0

Integrated healthy lifestyle even in late-life mitigates cognitive decline risk across varied genetic susceptibility

Integrated healthy lifestyle even in late-life mitigates cognitive decline risk across varied genetic susceptibility

admin January 13, 2025 0